Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets

Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

Novel Therapeutic Targets for Breast CancerПодробнее

Novel Therapeutic Targets for Breast Cancer

Novel Therapeutic Targets for Breast CancerПодробнее

Novel Therapeutic Targets for Breast Cancer

Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment StrategiesПодробнее

Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies

Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care PathwaysПодробнее

Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care Pathways

Keynote - Novel Therapeutics in Cancer (Jose Baselga)Подробнее

Keynote - Novel Therapeutics in Cancer (Jose Baselga)

Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer InstituteПодробнее

Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer Institute